⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
POI / Ovarian-Aging Protein Biomarkers (EPHA4, FSTL3, NUCB2)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-15 — CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes: cross-connection with cenp-v-oocyte-damage-marker: Both target ovarian-aging biomarker discovery but at different compartments — CENP-V inside the oocyte itself vs. granulosa-cell-derived plasma proteins (EPHA4/FSTL3/NUCB2). (novelty: 3)
- 2026-07-20 — Theca cells: active orchestrators of ovarian aging.: Review on theca-cell ovarian aging highlights that granulosa-focused biomarker panels (EPHA4/FSTL3/NUCB2) may miss upstream theca-compartment dysfunction (senescence, SASP, steroidogenic failure) that drives follicular atresia — reframing, not new biomarker evidence. [mechanism-plausible] (novelty: 3)
- 2026-08-28 — Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.: Integrated plasma proteomic Mendelian randomization plus colocalization prioritized seven high-confidence causal protein targets for premature ovarian insufficiency, with EPHA4, FSTL3, and NUCB2 validated in cisplatin-induced granulosa-cell injury models and molecular docking suggesting drug-repurposing leads (e.g., cycloheximide–EPHA4) — human genetic causal inference plus in vitro confirmation, no human therapeutic readout. [human-observational] (novelty: 3)
Open questions
Related
Contributing findings
Decoding the immune regulation of ovarian aging: mechanisms and therapeutic strategies.
09-oct-2026
novelty 3
per-area 2
mentions
CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes
15-sep-2026
novelty 3
per-area 2
mentions
Genetic Epidemiology of Ovarian Aging
15-sep-2026
novelty 2
per-area 1
mentions
Identifying novel druggable targets and repurposable drugs for premature ovarian insufficiency by integrated multiomics and causal inference analysis.
28-aug-2026
novelty 3
per-area 3
strengthens
Theca cells: active orchestrators of ovarian aging.
20-jul-2026
novelty 3
per-area 3
strengthens